|
|||||
|
|
| 城区与偏远山区复治耐多药肺结核的临床疗效比较 | |
| 引用本文： | 姚永秀,杨晓梅,刘娅. 城区与偏远山区复治耐多药肺结核的临床疗效比较[J]. 临床肺科杂志, 2005, 10(4): 453-454 |
| 作者姓名： | 姚永秀 杨晓梅 刘娅 |
| 作者单位： | 400020,重庆市肺科医院;重庆市结核病防治所 |
| 摘 要： | 目的比较重庆市城区和偏远山区复治耐多药肺结核接受以KPO1321为主的抗痨方案疗效的差异。方法回顾性总结91例复治耐多药患者接受该方案试疗3～6月的痰菌阴转率,比较两者的差异。结果城区50例,3月痰菌阴转率为44%,6月为66%;偏远山区41例,3月痰菌阴转率为73.17%,6月为85.36%,二者比较有显著性差异。结论偏远山区复治耐多药肺结核对该方案的疗效明显优于城区。 |
| 关 键 词： | 结核 肺/耐多药 临床疗效 |
| 修稿时间： | 2004-12-22 |
Comparing the clinical efficacy between the city area and secluded mountain area in MDR-TB |
|
| YAO YongXiu,Yang Xiaomei,LIU Ya. Comparing the clinical efficacy between the city area and secluded mountain area in MDR-TB[J]. Journal of Clinical Pulmonary Medicine, 2005, 10(4): 453-454 | |
| Authors: | YAO YongXiu Yang Xiaomei LIU Ya |
| Affiliation: | YAO YongXiu YANG Xiaomei LIU Ya Chongqin Pulomonlogy Hospital,Chongqin 400020,China |
| Abstract: | Objective To compare the clinical efficacy between the city area and the secluded mountain area with the project of KOPTH 1321 in treating MDR-TB. Methods A total of 91 patients with MDR-TB treated for 3~6 months with the drugs. Results The sputum M. tuberculosis clearance rates were 44% in the city and 73.17% in the mountain area after 3 months (P<0.01), 66% in the city and 85.36% in the mountain area (P<0.05) after 6 months. There were singnificant differences in the two groups in the rate comparisons.Conclusion The clinical efficacy of MDR-TB in secluded mountain area is better than that in the city area. |
| Keywords: | multiple drug resitant pulmonary tuberculosis (MDR-TB) clinical efficacy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |